Pilot Testing a Web-Based System for the Assessment and Management of Chemotherapy-Induced Peripheral Neuropathy

Area of Science:

• Oncology
• Patient Care Technology
• Neurology

Background:

• Chemotherapy-induced peripheral neuropathy (CIPN) presents significant clinical challenges.
• Existing assessment and management strategies are often hindered by practical barriers.
• Novel digital health solutions are needed to improve CIPN care delivery.

Purpose of the Study:

• To evaluate patient and provider perspectives on the feasibility, usability, acceptability, and satisfaction with the Carevive Care Planning System.
• To assess the potential of a web-based platform in managing CIPN symptoms.
• To identify barriers and facilitators for adopting digital health tools in oncology care.

Main Methods:

• A single-arm, pretest/posttest, prospective study design was employed.
• Twenty-five women with breast cancer undergoing neurotoxic chemotherapy participated.
• Six advanced practice providers were recruited from an academic hospital setting.
• Patients reported neuropathy symptoms via the Carevive system on a tablet during three consecutive clinic visits.
• The Diffusion of Innovations Theory guided the evaluation framework.

Main Results:

• The Carevive platform demonstrated feasibility for use in clinical practice.
• Patients reported higher usability, acceptability, and satisfaction compared to providers.
• Providers expressed dissatisfaction related to the time commitment and login difficulties associated with the platform.

Conclusions:

• The Carevive platform shows promise for screening neuropathy symptoms and implementing evidence-based management strategies.
• Addressing provider-related issues, such as time and technical access, is crucial for successful adoption.
• Further refinement of the platform may enhance its utility in routine oncology care for CIPN management.